Globus Medical North America Inc manufactures and distributes musculoskeletal devices spanning spine, trauma, joint reconstruction, and regenerative biologics. Founded in 2003 and publicly traded on NYSE (GMED), the company operates with approximately 5,300–6,000 employees and maintains a worldwide presence. The product portfolio includes ExcelsiusGPS™, a robotic navigation system for surgery; comprehensive spine procedure solutions; orthopedic trauma systems; joint reconstruction products; and biologic offerings for regenerative approaches.
The company's technical work spans the full stack of surgical device development: hardware design, embedded systems, clinical validation, and manufacturing at scale. ExcelsiusGPS represents the robotics integration point - a navigation platform deployed in operating rooms to assist surgeons in spine and orthopedic procedures. Beyond devices, Globus operates MERC Academy and state-of-the-art research laboratories, indicating sustained investment in both clinical education and product development infrastructure.
The engineering scope encompasses mechanical design, control systems, software architecture for intraoperative guidance, biocompatible materials, and the manufacturing processes required to scale devices across multiple surgical domains. Work centers on solving specific clinical problems in musculoskeletal care - instrumentation precision, anatomical complexity, and the constraints of the operating room environment.